| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |